These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 30698109)

  • 1. The Adverse Events Rate of Endothelial Progenitor Cell Capturing Stent in the Treatment of CAD Patients.
    Xu WY; Tang WL; Yuan M; Sun Y; Xu F; Peng F
    Comb Chem High Throughput Screen; 2018; 21(10):725-733. PubMed ID: 30698109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-year follow-up of the Genous™ endothelial progenitor cell capturing stent versus the Taxus Liberté stent in patients with de novo coronary artery lesions with a high-risk of restenosis: a randomized, single-center, pilot study.
    Beijk MA; Klomp M; van Geloven N; Koch KT; Henriques JP; Baan J; Vis MM; Tijssen JG; Piek JJ; de Winter RJ
    Catheter Cardiovasc Interv; 2011 Aug; 78(2):189-95. PubMed ID: 21542109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and effectiveness of the Genous endothelial progenitor cell-capture stent: follow-up to 5 years.
    Pereira-da-Silva T; Bernardes L; Cacela D; Fiarresga A; Sousa L; Patrício L; Ferreira RC
    J Invasive Cardiol; 2013 Dec; 25(12):666-9. PubMed ID: 24296387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-year results of a randomized comparison of XIENCE V everolimus-eluting and TAXUS paclitaxel-eluting stents: final results from the SPIRIT III trial (clinical evaluation of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo native coronary artery lesions).
    Gada H; Kirtane AJ; Newman W; Sanz M; Hermiller JB; Mahaffey KW; Cutlip DE; Sudhir K; Hou L; Koo K; Stone GW
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1263-6. PubMed ID: 24239202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five-year follow-up of the endothelial progenitor cell capturing stent versus the paxlitaxel-eluting stent in de novo coronary lesions with a high risk of coronary restenosis.
    Woudstra P; Kalkman DN; Beijk MA; Klomp M; Damman P; Koch KT; Henriques JPS; Baan J; Vis MM; Piek JJ; Tijssen JGP; de Winter RJ
    Catheter Cardiovasc Interv; 2018 Jun; 91(7):1212-1218. PubMed ID: 28868810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial Progenitor Cells in Coronary Atherosclerosis and Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis.
    Pelliccia F; Pasceri V; Zimarino M; De Luca G; De Caterina R; Mehran R; Dangas G
    Cardiovasc Revasc Med; 2022 Sep; 42():94-99. PubMed ID: 35246408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
    Dangas GD; Serruys PW; Kereiakes DJ; Hermiller J; Rizvi A; Newman W; Sudhir K; Smith RS; Cao S; Theodoropoulos K; Cutlip DE; Lansky AJ; Stone GW
    JACC Cardiovasc Interv; 2013 Sep; 6(9):914-22. PubMed ID: 24050859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A clinical and angiographic study of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with multivessel coronary artery disease: the EXECUTIVE trial (EXecutive RCT: evaluating XIENCE V in a multi vessel disease).
    Ribichini F; Romano M; Rosiello R; La Vecchia L; Cabianca E; Caramanno G; Milazzo D; Loschiavo P; Rigattieri S; Musarò S; Pironi B; Fiscella A; Amico F; Indolfi C; Spaccarotella C; Bartorelli A; Trabattoni D; Della Rovere F; Rolandi A; Beqaraj F; Belli R; Sangiorgio P; Villani R; Berni A; Sheiban I; Lopera Quijada MJ; Cappi B; Ribaldi L; Vassanelli C;
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1012-22. PubMed ID: 24055444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous coronary intervention utilizing a new endothelial progenitor cells antibody-coated stent: a prospective single-center registry in high-risk patients.
    Miglionico M; Patti G; D'Ambrosio A; Di Sciascio G
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):600-4. PubMed ID: 18360849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiplatelet theRapy after Genous EPC-capturing coroNary stenT implantatiOn: the ARGENTO study: a prospective, multicenter registry.
    Cassese S; Galasso G; Sciahbasi A; Scacciatella P; Muçaj A; Piccolo R; D'Anna C; Pangrazi A; Lioy E; Marra S; Piscione F
    Int J Cardiol; 2013 Aug; 167(3):757-61. PubMed ID: 22459371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of drug-eluting balloons alone or in combination with drug-eluting stents in the treatment of de novo diffuse coronary disease.
    Costopoulos C; Latib A; Naganuma T; Sticchi A; Figini F; Basavarajaiah S; Carlino M; Chieffo A; Montorfano M; Naim C; Kawaguchi M; Giannini F; Colombo A
    JACC Cardiovasc Interv; 2013 Nov; 6(11):1153-9. PubMed ID: 24262615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 9-year clinical follow-up of patients with ST-segment elevation myocardial infarction with Genous or TAXUS Liberté stents.
    Giurgea GA; Heuberger A; Babayev J; Winkler S; Schlager O; Lang IM; Gyöngyösi M
    PLoS One; 2018; 13(8):e0201416. PubMed ID: 30080886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-year clinical registry follow-up of endothelial progenitor cell capture stent versus sirolimus-eluting bioabsorbable polymer-coated stent versus bare metal stents in patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction.
    Chong E; Poh KK; Liang S; Lee RC; Low A; Teo SG; Tan HC
    J Interv Cardiol; 2010 Apr; 23(2):101-8. PubMed ID: 20236214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating endothelial progenitor cells predict angiographic and intravascular ultrasound outcome following percutaneous coronary interventions in the HEALING-II trial: evaluation of an endothelial progenitor cell capturing stent.
    Duckers HJ; Silber S; de Winter R; den Heijer P; Rensing B; Rau M; Mudra H; Benit E; Verheye S; Wijns W; Serruys PW
    EuroIntervention; 2007 May; 3(1):67-75. PubMed ID: 19737687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term clinical observations for a biofunctionalized stent: Yet to deliver their theoretical benefits.
    Nakamura K; Dean LS
    Catheter Cardiovasc Interv; 2018 Jun; 91(7):1219-1220. PubMed ID: 29894587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of olmesartan on the levels of circulating endothelial progenitor cell after drug-eluting stent implantation in patients receiving statin therapy.
    Aoki J; Kozuma K; Tanabe K; Tanimoto S; Nakajima Y; Yahagi K; Hashimoto T; Isshiki T; Hara K
    J Cardiol; 2014 Dec; 64(6):435-40. PubMed ID: 24768407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial Progenitor Cells in Coronary Artery Disease: From Bench to Bedside.
    Pelliccia F; Zimarino M; De Luca G; Viceconte N; Tanzilli G; De Caterina R
    Stem Cells Transl Med; 2022 May; 11(5):451-460. PubMed ID: 35365823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating endothelial progenitor cells are inversely correlated with in-stent restenosis in patients with non-ST-segment elevation acute coronary syndromes treated with EPC-capture stents (JACK-EPC trial).
    Wojakowski W; Pyrlik A; Król M; Buszman P; Ochała A; Milewski K; Smolka G; Kawecki D; Rudnik A; Pawłowski T; Jadczyk T; Wyderka R; Cybulski W; Dworowy S; Tendera M
    Minerva Cardioangiol; 2013 Jun; 61(3):301-11. PubMed ID: 23681133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and angiographic outcomes in elderly patients treated with endothelial progenitor cell capture coronary stents: results from a prospective single-center registry.
    Azzarelli S; Galassi AR; Grosso G; Tomasello D; Campisano B; Giacoppo M; Argentino V; Amico F; Fiscella A
    J Invasive Cardiol; 2010 Dec; 22(12):594-8. PubMed ID: 21127365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficiency of statin treatment on EPC recruitment depends on baseline EPC titer and does not improve angiographic outcome in coronary artery disease patients treated with the Genous stent.
    den Dekker WK; Houtgraaf JH; Rowland SM; Ligtenberg E; de Boer SP; de Jong R; de Winter RJ; den Heijer P; Zijlstra F; Serruys PW; Cheng C; Duckers HJ
    Cell Transplant; 2014; 23(12):1525-35. PubMed ID: 23561893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.